CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +247.2% | +18.7% | -50.9% | -94.0% | +1,418.3% | +339.4% | -15.3% | -74.1% | +640.7% | |
| – | +81.0% | +165.1% | +69.6% | +37.3% | -97.8% | +10.1% | -21.0% | +153.6% | -61.4% | |
| – | – | – | -50.9% | -94.0% | +1,418.3% | +339.4% | -15.3% | -74.1% | +537.2% | |
| – | +81.0% | +165.1% | +69.6% | +37.3% | +47.8% | +54.6% | +29.4% | +42.5% | +38.3% | |
| – | +26.5% | +243.4% | +103.0% | +33.3% | +36.1% | +72.9% | +37.0% | +71.7% | +91.8% | |
| – | +51.0% | +214.6% | +87.5% | +39.2% | +45.1% | +58.7% | +31.3% | +50.0% | +54.0% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -27.3% | -100.0% | – | – | -93.8% | +6,977.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -500.0% | – | -155.6% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.